| 2024-11-12 | +0.14 % |
|
| 2024-11-08 | +1.4 % |
|
| 2024-11-01 | -0.51 % |
|
| 2024-10-31 | -0.99 % |
|
| 2024-10-30 | +1.08 % |
|
| 2024-10-29 | +0.31 % |
|
| 2024-10-28 | -0.55 % |
|
| 2024-10-25 | -0.63 % |
|
| 2024-10-24 | +4.62 % |
|
| 2024-10-23 | -0.28 % |
|
| 2024-10-22 | +2.98 % |
|
| 2024-10-21 | -0.76 % |
|
| 2024-10-18 | +0.3 % |
|
| 2024-10-14 | +0.21 % |
|
| 2024-10-10 | -0.32 % |
|
| 2024-10-07 | -1.83 % |
|
| 2024-10-03 | -1.79 % |
|
| 2024-10-02 | -0.09 % |
|
| 2024-10-01 | -1.92 % |
|
| 2024-09-24 | -1.83 % |
|
| 2024-09-20 | -1.06 % |
|
| 2024-09-11 | -0.93 % |
|
| 2024-09-06 | -1.51 % |
|
| 2024-09-04 | -0.71 % |
|
| 2024-08-13 | +0.54 % |
|
| 2024-08-12 | -1.38 % |
|
| 2024-08-08 | +2.45 % |
|
| 2024-08-07 | -2.88 % |
|
| 2024-08-05 | -3.15 % |
|
| 2024-08-01 | +8.33 % |
|
| 2024-07-23 | -3.38 % |
|
| 2024-07-19 | -1.53 % |
|
| 2024-07-18 | -0.52 % |
- Labcorp (LH) stock was down -0.52% as reported on July 18th, 2024; the stock likely experienced a decline due to insider selling activities and institutional investors modifying their holdings, including Empowered Funds LLC increasing its position by 185.4% and several other large investors either purchasing or increasing stakes in Laboratory Co. of America Holdings, while also insider selling activities were prevalent.
- Summary: Hedge funds and institutional investors have been increasing their holdings in Laboratory Co. of America Holdings (LH), with Headlands Technologies LLC growing their stake by 18.2% in the first quarter. Despite positive analyst ratings, LH stock was down by 0.52% last night. The stock may have experienced a downturn due to general market conditions or profit-taking behavior following recent price increases.
Labcorp (LH) stock goes down due to various reasons such as market conditions, profit-taking behavior by investors following recent price increases, and potential concerns about the company's performance or outlook.
- The article provides an overview of Labcorp (LH) stock, noting that it was down -0.52% the previous night, with US Bancorp DE reducing its position in Laboratory Co. of America Holdings in the first quarter, leading to a decrease in the stock price. The decrease in the stock price may be attributed to institutional investors like US Bancorp DE reducing their holdings in the company, which could have contributed to the downward pressure on the stock. Additionally, recent insider selling of the stock may have also impacted the stock price.
|
| 2024-07-17 | -0.33 % |
- Labcorp (LH) stock went down last night by -0.33% after analysts at Leerink Partners reduced their FY2026 earnings per share estimates for Laboratory Co. of America, citing a decrease in the expected earnings for the year.
- The article discusses the comparison between Laboratory Co. of America (NYSE:LH) and BioNexus Gene Lab (NASDAQ:BGLC) in terms of profitability, analyst recommendations, risk, earnings, valuation, institutional ownership, and dividends, with Laboratory Co. of America having higher revenue, earnings, and price targets, indicating its superiority. The Labcorp (LH) stock went down last night by -0.33%, possibly influenced by various factors such as market conditions, industry trends, or specific company news impacting investor sentiment.
- The article discusses Oppenheimer & Co. Inc. boosting its holdings in Laboratory Co. of America Holdings (NYSE:LH) by 2.2% during the 1st quarter, with various other institutional investors also buying shares, yet the stock of Labcorp went down by -0.33% last night; the reason for the stock decrease is not explicitly mentioned in the article, usually stock price fluctuations can be influenced by a variety of factors, including market sentiment, economic conditions, company performance, industry news, and investor behavior.
|
| 2024-07-16 | +4.34 % |
|
| 2024-07-15 | +0.64 % |
- Summary: Truist Securities adjusted its price target for Quest Diagnostics stock higher, attributing the increase to the company's strong base business trends, successful execution of growth opportunities, including M&A activities, and financial flexibility; LabCorp stock was up due to positive outlook for diagnostics industry and favorable trends in central lab services.
LabCorp stock goes up due to the positive outlook on the diagnostics industry, LabCorp's pending acquisitions, and favorable trends in central lab services in addition to its own M&A activities.
- The Labcorp (LH) stock went up 0.64% last night due to Onconetix, Inc. closing the exercise of certain existing warrants and using the proceeds for working capital and general corporate purposes, as part of a transaction with H.C. Wainwright acting as the exclusive placement agent.
- Summary: Forsta AP Fonden increased its holdings in Laboratory Co. of America Holdings (NYSE:LH) by 9.5% in the 1st quarter, resulting in a 0.64% increase in the stock. The stock went up as multiple institutional investors, including Forsta AP Fonden and Mendota Financial Group LLC, bought additional shares of Laboratory Co. of America stock, indicating growing interest and confidence in the company's future performance.
Reason for Stock Increase: The stock of Laboratory Co. of America Holdings (NYSE:LH) went up as several institutional investors, such as Forsta AP Fonden and Mendota Financial Group LLC, bought additional shares of the company, showcasing increased confidence in its future performance and potential growth.
|
| 2024-07-11 | +2.93 % |
|
| 2024-07-08 | -0.79 % |
|
| 2024-07-03 | +0.56 % |
|
| 2024-07-02 | -0.2 % |
|
| 2024-07-01 | -0.19 % |
|
| 2024-06-28 | -0.68 % |
|
| 2024-06-17 | +0.84 % |
|
| 2024-06-12 | +0.22 % |
|
| 2024-06-11 | +0.77 % |
|
| 2024-06-07 | -0.91 % |
|
| 2024-06-04 | +0.86 % |
- The article discusses Diamond Hill Capital's first-quarter 2024 investor letter, highlighting their investment in stocks like BorgWarner Inc. (NYSE:BWA) and Laboratory Corporation of America (LabCorp), with LabCorp stock rising by 0.86% last night. LabCorp's stock goes up due to positive returns in the first quarter of 2024, potential growth opportunities, and the ongoing shift to electric vehicles and hybrids impacting BorgWarner negatively.
- Labcorp Holdings Inc. (NYSE:LH) stock was up 0.86% last night, with Diamond Hill Capital's Large Cap Strategy highlighting the company in its first quarter 2024 investor letter, expressing optimism about Labcorp's leading position in the US diagnostic lab market, scale advantages, attractive valuation, and significant free cash flow generation, despite management setting expectations for a slower 2024.
|
| 2024-06-03 | +0.05 % |
|
| 2024-05-30 | +0.49 % |
- Labcorp (LH) stock went up by 0.49% last night, and the increase can be attributed to Nomura Asset Management Co. Ltd. and other hedge funds increasing their positions in Laboratory Co. of America Holdings (LH) stock as reported in a recent Form 13F filing.
- The article discusses Laboratory Co. of America Holdings (NYSE:LH) stock, which saw a 0.49% increase in value, highlighting how various institutional investors like Advisory Services Network LLC, Wellington Management Group LLP, Morgan Stanley, Lazard Asset Management LLC, Norges Bank, and Northern Trust Corp have added to their stakes in the company. The stock reportedly rose due to positive earnings results, beating estimates, with a return on equity of 14.68% and a net margin of 3.52%, as well as news of a quarterly dividend being announced.
|
| 2024-05-29 | -1.88 % |
|
| 2024-05-28 | -1.73 % |
|
| 2024-05-24 | +1.3 % |
|
| 2024-05-23 | -2.04 % |
|
| 2024-05-21 | -0.72 % |
|
